CAS No 151767-02-1 |
Montelukast Sodiumnull |
Inquiry |
CAS No 15186-48-8 |
2,3-O-isopropylidene- D-glyceraldehydenull |
Inquiry |
CAS No 151257-01-1 |
2-n-Butyl-1,3-diaza-spiro[4,4]non-1-en-4-one hydrochloridenull |
Inquiry |
CAS No 150727-06-3 |
4-tert-Butyl-N-(6-chloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamidenull |
Inquiry |
CAS No 150728-12-4 |
5-(2-methoxyphenoxy)-[2,2'-Bipyrimidine]-4,6(1H,5H)-dionenull |
Inquiry |
CAS No 150026-75-8 |
Benzenepropanol, a-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-2-[(1R)-1-hydroxy-1-methylethyl]-null |
Inquiry |
CAS No 14847-51-9 |
Phenol,2-bromo-5-methyl-null |
Inquiry |
CAS No 14867-38-0 |
Vanadium,isotope of mass 47null |
Inquiry |
CAS No 14796-02-2 |
Benzamide,4,4'-[(2,3,5,6-tetrafluoro-p-phenylene)dioxy]bis[2,3,5,6-tetrafluoro- (8CI)null |
Inquiry |
CAS No 14767-09-0 |
Iodic acid (HIO3),thallium(1+) salt (8CI,9CI)null |
Inquiry |
CAS No 14788-65-9 |
4-Quinolinol,4-ethynyldecahydro-1,2-dimethyl-, (2R,4R,4aS,8aS)-rel-null |
Inquiry |
CAS No 14569-76-7 |
But-2-ynylene bis(chloroacetate)null |
Inquiry |
CAS No 145040-37-5 |
Candesartan Cilexetilnull |
Inquiry |
CAS No 145589-03-3 |
(R)-3-(3-methylbutanoyl)-4-benzyloxazolidin-2-onenull |
Inquiry |
CAS No 144701-48-4 |
Telmisartannull |
Inquiry |
CAS No 144690-92-6 |
Trityl Olmesartan Medoxomilnull |
Inquiry |
CAS No 144689-93-0 |
[5-(1-Hydroxyl-1-methylethyl)-2-propyl-imidazol-4-yl]carboxylic acid ethyl esternull |
Inquiry |
CAS No 144689-63-4 |
Olmesartan medoxomilnull |
Inquiry |
CAS No 144689-63-4; 144689-78-1 |
Olmesartan Medoxomilnull |
Inquiry |
CAS No 144143-96-4 |
Eprosartan Methanesulfonatenull |
Inquiry |
CAS No 143722-25-2 |
[2-[2-(Triphenylmethyl)-2H-tetrazol-5-yl]phenyl]boronic acidnull |
Inquiry |
CAS No 14389-13-0 |
5-propyl-2H-tetrazolenull |
Inquiry |
CAS No 143468-96-6 |
(2-Thienylmethyl)propanedioic acid monoethyl esternull |
Inquiry |
CAS No 143221-26-5 |
gp49 Surface antigennull |
Inquiry |
CAS No 143268-49-9 |
1H-Benzimidazole,2,3-dihydro-1,3-dimethyl-2-(1-methylethylidene)-null |
Inquiry |